They found that high expression levels of lncRNA DLX6-AS1 were associated with poor overall survival in tumor patients and overexpression of lncRNA DLX6-AS1 was associated with tumor stage (p < 0.01), tumor size (p < 0.01), lymph node metastasis (p < 0.01), and distant metastasis (p < 0.01). The gene discussed is DLX6; the disease is neoplasm.